194 related articles for article (PubMed ID: 27647299)
1. Lung Cancer Screening Eligibility in the Community: Cardiovascular Risk Factors, Coronary Artery Calcification, and Cardiovascular Events.
Lu MT; Onuma OK; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
Circulation; 2016 Sep; 134(12):897-9. PubMed ID: 27647299
[No Abstract] [Full Text] [Related]
2. Extracoronary Thoracic and Coronary Artery Calcifications on Chest CT for Lung Cancer Screening: Association with Established Cardiovascular Risk Factors - The "CT-Risk" Trial.
Dirrichs T; Penzkofer T; Reinartz SD; Kraus T; Mahnken AH; Kuhl CK
Acad Radiol; 2015 Jul; 22(7):880-9. PubMed ID: 25957500
[TBL] [Abstract][Full Text] [Related]
3. Quantification of coronary artery calcium in nongated CT to predict cardiovascular events in male lung cancer screening participants: results of the NELSON study.
Takx RA; Išgum I; Willemink MJ; van der Graaf Y; de Koning HJ; Vliegenthart R; Oudkerk M; Leiner T; de Jong PA
J Cardiovasc Comput Tomogr; 2015; 9(1):50-7. PubMed ID: 25533223
[TBL] [Abstract][Full Text] [Related]
4. Lung Cancer Screening Eligible?
Yeboah J
Circulation; 2018 Dec; 138(25):2867-2868. PubMed ID: 30566015
[No Abstract] [Full Text] [Related]
5. Frequency of coronary artery calcification on low-dose computed tomography screening for lung cancer.
Shemesh J; Henschke CI; Farooqi A; Yip R; Yankelevitz DF; Shaham D; Miettinen OS
Clin Imaging; 2006; 30(3):181-5. PubMed ID: 16632153
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery calcification scoring in low-dose ungated CT screening for lung cancer: interscan agreement.
Jacobs PC; Isgum I; Gondrie MJ; Mali WP; van Ginneken B; Prokop M; van der Graaf Y
AJR Am J Roentgenol; 2010 May; 194(5):1244-9. PubMed ID: 20410410
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of significant noncardiac findings on electron-beam computed tomography coronary artery calcium screening examinations.
Horton KM; Post WS; Blumenthal RS; Fishman EK
Circulation; 2002 Jul; 106(5):532-4. PubMed ID: 12147531
[TBL] [Abstract][Full Text] [Related]
8. Coronary artery calcification detected in lung cancer screening predicts cardiovascular death.
Rasmussen T; Køber L; Abdulla J; Pedersen JH; Wille MM; Dirksen A; Kofoed KF
Scand Cardiovasc J; 2015 Jun; 49(3):159-67. PubMed ID: 25919145
[TBL] [Abstract][Full Text] [Related]
9. Relationship and prognostic value of modified coronary artery calcium score, FEV1, and emphysema in lung cancer screening population: the MILD trial.
Sverzellati N; Cademartiri F; Bravi F; Martini C; Gira FA; Maffei E; Marchianò A; La Vecchia C; De Filippo M; Kuhnigk JM; Rossi C; Pastorino U
Radiology; 2012 Feb; 262(2):460-7. PubMed ID: 22114241
[TBL] [Abstract][Full Text] [Related]
10. Visual scoring of coronary artery calcification in lung cancer screening computed tomography: association with all-cause and cardiovascular mortality risk.
Watts JR; Sonavane SK; Snell-Bergeon J; Nath H
Coron Artery Dis; 2015 Mar; 26(2):157-62. PubMed ID: 25370000
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer screening CT-based prediction of cardiovascular events.
Mets OM; Vliegenthart R; Gondrie MJ; Viergever MA; Oudkerk M; de Koning HJ; Mali WP; Prokop M; van Klaveren RJ; van der Graaf Y; Buckens CF; Zanen P; Lammers JW; Groen HJ; Isgum I; de Jong PA
JACC Cardiovasc Imaging; 2013 Aug; 6(8):899-907. PubMed ID: 23769488
[TBL] [Abstract][Full Text] [Related]
12. Beyond lung cancer: a strategic approach to interpreting screening computed tomography scans on the basis of mortality data from the National Lung Screening Trial.
Chiles C; Paul NS
J Thorac Imaging; 2013 Nov; 28(6):347-54. PubMed ID: 24071622
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer.
Jacobs PC; Gondrie MJ; van der Graaf Y; de Koning HJ; Isgum I; van Ginneken B; Mali WP
AJR Am J Roentgenol; 2012 Mar; 198(3):505-11. PubMed ID: 22357989
[TBL] [Abstract][Full Text] [Related]
14. [Not Available].
Leduc D
Rev Med Brux; 2018; 39(2):69. PubMed ID: 29722487
[No Abstract] [Full Text] [Related]
15. Lung cancer screening--comparison of computed tomography and X-ray.
Fujikawa A; Takiguchi Y; Mizuno S; Uruma T; Suzuki K; Nagao K; Niijima M; Edo H; Hino M; Kuriyama T
Lung Cancer; 2008 Aug; 61(2):195-201. PubMed ID: 18242764
[TBL] [Abstract][Full Text] [Related]
16. Broadened Eligibility for Lung Cancer Screening: Challenges and Uncertainty for Implementation and Equity.
Henderson LM; Rivera MP; Basch E
JAMA; 2021 Mar; 325(10):939-941. PubMed ID: 33687453
[No Abstract] [Full Text] [Related]
17. [Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants].
Tang W; Wu N; Huang Y; Wang J; Zhao S; Xu Z; Zhang K; Jiang Y; Cai Q; Zhou L; Li M; Tao D; Liu X; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):549-54. PubMed ID: 25327664
[TBL] [Abstract][Full Text] [Related]
18. Lung Cancer Screening in a Safety-Net Hospital: Implications of Screening a Real-World Population versus the National Lung Screening Trial.
Iaccarino JM; Steiling KA; Wiener RS
Ann Am Thorac Soc; 2018 Dec; 15(12):1493-1495. PubMed ID: 30199643
[No Abstract] [Full Text] [Related]
19. Benefits and Challenges of Lung Cancer Screening in Older Adults.
Fabrikant MS; Wisnivesky JP; Marron T; Taioli E; Veluswamy RR
Clin Ther; 2018 Apr; 40(4):526-534. PubMed ID: 29573852
[TBL] [Abstract][Full Text] [Related]
20. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
